The Champion for Rare Disease Cures
An entrepreneur with his own rare disease finds a way to align incentives and needs to support research on rare diseases.
As psychedelics are integrated into mainstream medicine, experts weigh the benefits and costs of solo versus group therapy.
She Has Stem Cells in Her Crosshairs
Bone marrow transplants are harrowing. Agnieszka Czechowicz is working to make them safer.
Living Pharmacies Could Remedy Disrupted Sleep
DARPA is developing an implantable device with bioengineered cells for treating everything from traveler’s diarrhea to jet lag.
How Did HIV/AIDS Prepare Us for COVID-19?
Forty years after a 1981 report hinted at the coming HIV/AIDS pandemic, we look at how the response to global public health threats has changed.
The Sex, Lies, and Videotape of Cancer Cells
Cells we were taught to ignore have been caught on tape doing the unthinkable.
The Future of Chronic Pain
For the millions of people suffering with daily physical pain, nerve stimulation and gene editing offer new hope beyond addictive opioids.
The Case for More Doping in the Olympics
Some tech and drug enhancements are banned as unfair, but ironically they could end up leveling the playing field.
AI Breathes New Life into Old Drugs
Deep learning uncovers the potential of existing medications to target different diseases.
Lithium: The Next Trend in Microdosing?
Low levels of the naturally occurring, soft shiny metal could reduce violence and enhance moods for all.
Inside the Movement to Decolonize Psychedelic Pharma
As Western medicine brings psychedelics into mainstream use, a growing movement is innovating new business models grounded in reciprocity and inclusion.
There Might Be a Better Time to Pop That Pill
Syncing cures with circadian rhythms is an idea whose moment has finally come.
Take These Drugs to Get to Mars
Space brain and other cosmic problems demand new kinds of pharmaceutical protection.